Evidence map›Paper›PMID 41121131›Full record

ArticleBMC pulmonary medicine2025

Global, regional, and national burden of asthma from 1990 to 2021: analysis of data from global disease burden in 2021.

Cong Hu, Shuxiong Nong, Yixin Chen, Lin Zhang, Yongfeng Chen, Chenang Liu, Ping Li, Chilin Liao, Meng Wu

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Frontiers in immunology · 2026
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cong Hu *Department of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China. conghu@whu.edu.cn.
Shuxiong Nong *Department of Cardiology, Baise People's Hospital, Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China.
Yixin Chen *Department of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
Lin Zhang *Department of Anesthesiology, Shanxi Provincial People's Hospital, Taiyuan, 030012, China.
Yongfeng ChenDepartment of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
Chenang LiuDepartment of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China.
Ping LiDepartment of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China. znyylp@163.com.
Chilin LiaoDepartment of Cardiology, Baise People's Hospital, Affiliated Southwest Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China.
Meng WuDepartment of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China. wb000713@whu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma is one of the diseases that pose a serious threat to human health globally. The Global Burden of Disease (GBD) study from 1990 to 2021 conducted a comprehensive assessment of the prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALY) of asthma. This study particularly focuses on the integration of prevalence data with other indicators and carries out stratified analyses at the global, regional, and national levels based on gender, age, and Socio-Demographic Index (SDI).

methodsThe data for this study is drawn from the 2021 Global Burden of Disease (GBD) study, which provides comprehensive data on diseases, injuries, and risk factors. This study aims to explore the temporal trends of asthma and assess the dynamics of age-standardized prevalence rates (ASPR), incidence rates (ASIR), death rates (ASDR), and disability-adjusted life years (DALYs) for asthma, with the goal achieved by estimating the annual percentage change (EAPC) over the study period. The study conducted a detailed stratification based on gender, 20 age groups, 21 GBD regions, 204 countries and territories, and 5 SDI quintiles.

resultsIn 2021, asthma continued to impose a substantial burden on the global health landscape, with a total of 260479186.9 (227209547.5-297967236.9) cases and an ASPR of 3340.1 (2905.2-3832.2 per 100,000 people. The ASIR was 37864175.4 (31381241-46919993.7), translating to 516.7 (425.4-646.1) per 100,000 people. In 2021, the number of disability-adjusted life years (DALYs) attributed to asthma was 21422859.9 (16956877.7-26887091.7), and the ASDR was 264.6 (208.3-333.4) per 100,000 people. Analyzing regional disparities, it was observed that High SDI regions had the highest ASPR, and ASIR, while Low SDI regions had the lowest ASDR and Age-standardized DALY rates. Geographically, Kazakstan and Pakistan stood out with the high ASPR, and Papua New Guinea stood out with the highest ASDR, and Age-standardized DALY rates. Asthma primarily affects minors, with no significant difference between males and females. High BMI has emerged as the most important risk factor for asthma-related DALYs globally.

conclusionThis pattern indicates a complex relationship between socio-economic development and health outcomes. Regions with higher Socio-Demographic Index (SDI), which typically represent more developed areas, tend to have a higher prevalence of asthma but lower mortality rates and disease burden. These patterns highlight the necessity for low-income regions to learn from the targeted public health measures of high-income areas in developing asthma management plans, in order to address the inequalities in asthma outcomes.

Indexed as

AsthmaGlobal Burden of DiseaseAdolescentAdultAgedChildChild, PreschoolCost of IllnessDisability-Adjusted Life YearsFemaleGlobal HealthHumansIncidenceInfantMaleMiddle AgedAsthmaDALYGBDIncidence ratePrevalence

Identifiers

PMID41121131
PMCPMC12538757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.